ZA891524B - Platinum chemotherapeutic product - Google Patents

Platinum chemotherapeutic product

Info

Publication number
ZA891524B
ZA891524B ZA891524A ZA891524A ZA891524B ZA 891524 B ZA891524 B ZA 891524B ZA 891524 A ZA891524 A ZA 891524A ZA 891524 A ZA891524 A ZA 891524A ZA 891524 B ZA891524 B ZA 891524B
Authority
ZA
South Africa
Prior art keywords
platinum chemotherapeutic
chemotherapeutic product
product
platinum
chemotherapeutic
Prior art date
Application number
ZA891524A
Other languages
English (en)
Inventor
Kenneth Reginald Harrap
Reginald Harrap Kenneth
Original Assignee
Johnson Matthey Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson Matthey Plc filed Critical Johnson Matthey Plc
Publication of ZA891524B publication Critical patent/ZA891524B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA891524A 1988-03-16 1989-02-28 Platinum chemotherapeutic product ZA891524B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888806224A GB8806224D0 (en) 1988-03-16 1988-03-16 Platinum chemotherapeutic product

Publications (1)

Publication Number Publication Date
ZA891524B true ZA891524B (en) 1989-10-25

Family

ID=10633521

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA891524A ZA891524B (en) 1988-03-16 1989-02-28 Platinum chemotherapeutic product

Country Status (13)

Country Link
US (1) US4892735A (de)
EP (1) EP0339772A1 (de)
JP (1) JPH0296523A (de)
KR (1) KR890014107A (de)
AU (1) AU613720B2 (de)
DK (1) DK105889A (de)
FI (1) FI890951A (de)
GB (1) GB8806224D0 (de)
IL (1) IL89502A0 (de)
NO (1) NO891122L (de)
NZ (1) NZ228267A (de)
PT (1) PT90027A (de)
ZA (1) ZA891524B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3689974T2 (de) * 1985-03-14 1994-11-03 Beecham Group Plc Arzneimittel zur Behandlung von Emesis.
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
FR2698871B1 (fr) 1992-12-09 1995-02-24 Rhone Poulenc Rorer Sa Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
US6190691B1 (en) 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
JPH10500669A (ja) * 1994-04-12 1998-01-20 アルザ・コーポレーション サイトカイン阻害薬に関するスクリーニング法
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
JP3492763B2 (ja) 1994-06-03 2004-02-03 エスエス製薬株式会社 白金錯体及びこれを含有する悪性腫瘍治療剤
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
US5849761A (en) 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
CA2385528C (en) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
AUPQ641100A0 (en) * 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
PL370867A1 (en) * 2001-09-24 2005-05-30 Tosk, Inc. Reduced toxicity cisplatin formulations and methods for using the same
ES2278115T3 (es) * 2003-10-13 2007-08-01 Zoser B. Nat.Rer.Dr. Salama Composicion farmaceutica que comprende oxoplatino y sus sales.
US8956161B2 (en) * 2008-11-04 2015-02-17 Duane C Keller Article and method for controlling oral-originated systemic disease

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714159A (en) * 1971-03-30 1973-01-30 Janssen Pharmaceutica Nv 2,2-diaryl-4-(4'-aryl-4'-hydroxy-piper-idino)-butyramides
US4175133A (en) * 1977-02-18 1979-11-20 United States Of America 1,2-Diaminocyclohexane platinum (II) complexes having antineoplastic activity against L1210 leukemia
US4116963A (en) * 1977-05-23 1978-09-26 G.D. Searle & Co. 3,3,3-triarylalkyl-4-phenylalkyl-4-hydroxy piperidines and related compounds
US4194045A (en) * 1977-12-27 1980-03-18 G. D. Searle & Co. 1-(3,3-Diaryl-3-oxadiazolalkyl)-4-phenyl-4-piperidinomethanols and related compounds
CA1158558A (en) * 1980-05-27 1983-12-13 Terence J. Ward Antidiarrhoeal agents
US4536386B1 (en) * 1981-01-26 1995-03-07 Robins Co Inc A H Method of controlling emesis caused by cisplatin in cancer chemotherapy
GB8328218D0 (en) * 1983-10-21 1983-11-23 Johnson Matthey Plc Oral compositions
US4599352A (en) * 1984-03-01 1986-07-08 The United States Of America As Represented By The Department Of Health And Human Services Antineoplastic platinum (IV) complexes and compositions
DE3689974T2 (de) * 1985-03-14 1994-11-03 Beecham Group Plc Arzneimittel zur Behandlung von Emesis.
GB8515845D0 (en) * 1985-06-22 1985-07-24 Beecham Group Plc Treatment
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
US4793986A (en) * 1987-02-25 1988-12-27 Johnson Matthey, Inc. Macromolecular platinum antitumor compounds

Also Published As

Publication number Publication date
NO891122L (no) 1989-09-18
PT90027A (pt) 1989-11-10
FI890951A (fi) 1989-09-17
IL89502A0 (en) 1989-09-10
AU3112789A (en) 1989-09-21
EP0339772A1 (de) 1989-11-02
NO891122D0 (no) 1989-03-15
KR890014107A (ko) 1989-10-21
GB8806224D0 (en) 1988-04-13
NZ228267A (en) 1990-12-21
FI890951A0 (fi) 1989-02-28
DK105889D0 (da) 1989-03-06
US4892735A (en) 1990-01-09
AU613720B2 (en) 1991-08-08
DK105889A (da) 1989-09-17
JPH0296523A (ja) 1990-04-09

Similar Documents

Publication Publication Date Title
HUT44919A (en) Cigarettelike product
PL255175A1 (en) Tobbaco product
EP0241838A3 (en) Antithrombogenic material
GB8807803D0 (en) Biochemical product
GB8511152D0 (en) Forming articles
GB8827986D0 (en) Chemical product
ZA891524B (en) Platinum chemotherapeutic product
GB8512243D0 (en) Shaped articles
GB8608762D0 (en) Encased product
GB8809440D0 (en) Aniline-resorcin-formaldehyde copoly-condensation product
GB8602909D0 (en) Vended product sensor
GB2219112B (en) Counter
GB8523567D0 (en) Sorting articles
GB8620692D0 (en) Powder-metallurgy articles
GB8829642D0 (en) Products
GB8808525D0 (en) Synthetic gene
GB8818775D0 (en) Synthetic gene
GB8512686D0 (en) Articles secured together
GB8818774D0 (en) Synthetic gene
GB8808523D0 (en) Synthetic gene
IE890622L (en) Chemotherapeutic product
CA62417S (en) Euchre counter
GB8813486D0 (en) Product
IE880321L (en) Probiotic-type product
GB8808524D0 (en) Synthetic gene